66 results Colour shifting risks: cartel fines for alleged indirect info exchange upheld National courts upheld the approach by two national competition authorities towards indirect information exchange, lowering the standard of proof for collusion by competitors when receiving competitively sensitive information from a buyer (or supplier). Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby. Stibbe wins four awards at the Benchmark Litigation Europe Awards 2021 Our Brussels office is honoured to have won four awards at the annual Benchmark Litigation Europe Awards ceremony last night. These awards celebrate the leading litigators and most impactful disputes across Europe. Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan. Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health. Stibbe advises Proximus on the sale of its majority stake in Be-Mobile Stibbe advises Belgian-listed company Proximus on the sale of its majority stake in Be-Mobile to Arrive. Stibbe represents Geberit Stibbe represented Geberit, a leading producer of sanitary systems, in unfair competition law procedures, injunction procedures, preliminary procedures, and seizure procedures. Stibbe advises the Antwerp Port Authority Stibbe advises the Antwerp Port Authority on its combination with the port of Zeebrugge. Stibbe advises care chain Goed Stibbe advised Goed, the network of pharmacies, home care shops and audiology shops of health insurance fund CM, on the sale of its hearing centres chain to Audika Belgium. Stibbe assists Goed Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma. Stibbe advises Aedifica on agreement with Cofinimmo to form Europe’s leading healthcare REIT Stibbe advised Aedifica on its proposed conditional exchange offer to Cofinimmo and the resulting agreement to combine and create Europe’s leading healthcare REIT. Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector. Stibbe advises APG and a joint venture partner Stibbe advises APG and a joint venture partner on the acquisition of an approximate 33% interest in HHR Euro C.V. from their joint venture partner Host Hotels & Resorts Inc. Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises Lotte Group Stibbe assisted South Korean conglomerate Lotte Group with its acquisition of Chocolaterie Guylian. Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Pagination Current page 1 Page 2 Page 3 Page 4 Next page
Colour shifting risks: cartel fines for alleged indirect info exchange upheld National courts upheld the approach by two national competition authorities towards indirect information exchange, lowering the standard of proof for collusion by competitors when receiving competitively sensitive information from a buyer (or supplier).
Stibbe advises Novy Stibbe assisted the shareholders of Novy with the sale of their shares to the American group Middleby.
Stibbe wins four awards at the Benchmark Litigation Europe Awards 2021 Our Brussels office is honoured to have won four awards at the annual Benchmark Litigation Europe Awards ceremony last night. These awards celebrate the leading litigators and most impactful disputes across Europe.
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
Het federale regeerakkoord door een publiekrechtelijke bril De nieuwe federale regering, die zichzelf een echte “hervormingsregering” noemt, heeft ambitieuze plannen voor het publiekrecht. In deze blogpost ontdek je enkele belangrijke hervormingen die de komende vijf jaar op de agenda staan.
Stibbe advises LDA Capital Stibbe assisted LDA Capital, a US-based global investment group, with its capital commitment agreement with Mithra, a company dedicated to Women's Health.
Stibbe advises Proximus on the sale of its majority stake in Be-Mobile Stibbe advises Belgian-listed company Proximus on the sale of its majority stake in Be-Mobile to Arrive.
Stibbe represents Geberit Stibbe represented Geberit, a leading producer of sanitary systems, in unfair competition law procedures, injunction procedures, preliminary procedures, and seizure procedures.
Stibbe advises the Antwerp Port Authority Stibbe advises the Antwerp Port Authority on its combination with the port of Zeebrugge.
Stibbe advises care chain Goed Stibbe advised Goed, the network of pharmacies, home care shops and audiology shops of health insurance fund CM, on the sale of its hearing centres chain to Audika Belgium.
Stibbe assists Goed Stibbe successfully assisted Goed on the sale of its pharmaceutical retail and wholesale business to Multipharma.
Stibbe advises Aedifica on agreement with Cofinimmo to form Europe’s leading healthcare REIT Stibbe advised Aedifica on its proposed conditional exchange offer to Cofinimmo and the resulting agreement to combine and create Europe’s leading healthcare REIT.
Stibbe advises DW Healthcare Partners Stibbe advised DW Healthcare Partners, a private equity investment firm, on the acquisition of CEFALY Technology, a company active in the healthcare sector.
Stibbe advises APG and a joint venture partner Stibbe advises APG and a joint venture partner on the acquisition of an approximate 33% interest in HHR Euro C.V. from their joint venture partner Host Hotels & Resorts Inc.
Webinar: The contraversial Bayer judgment and its potential impact on patent litigation in Europe Philippe Campolini, IP partner at Stibbe in Brussels, acts as panelist in a webinar organised by EPLAW (the European Patent Lawyers Association) on the contraversial Bayer judgment and its potential impact on patent litigation in Europe.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises Lotte Group Stibbe assisted South Korean conglomerate Lotte Group with its acquisition of Chocolaterie Guylian.
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.